Science current events, science news articles, research and discoveries.
Top science news articles and science current events stories from the past week.
Science Current Events Resources
Science Current Events and Science News RSS Feeds
Earth, Life and Space Science News and Current Events RSS Feeds.
|
 |
 |
 |
Recent Multiple Sclerosis Therapy Current Events | Multiple Sclerosis Therapy News
|
| Page
1 of
56 |
1391 Results |
|
|
|
Sort By:
Relevance | Page Views |
Combining targeted therapy drugs may treat previously resistant tumors A team of cancer researchers from several Boston academic medical centers has discovered a potential treatment for a group of tumors that have resisted previous targeted therapy approaches. view more (2008-12-01)
New treatment eliminates heel pain caused by plantar fasciitis Combining an ultrasound-guided technique with steroid injection is 95 percent effective at relieving the common and painful foot problem called plantar fasciitis, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). view more (2008-12-01)
Breast cancer treatment offers better outcome to women with implants Women with early-stage breast cancer who have undergone breast augmentation may be treated successfully with a partial-breast radiation treatment called brachytherapy, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA). view more (2008-12-01)
Estrogen therapy could be dangerous for women with existing heart risk Hormone therapy could accentuate certain pre-existing heart disease risk factors and a heart health evaluation should become the norm when considering estrogen replacement, new research suggests. view more (2008-11-26)
Melatonin may save eyesight in inflammatory disease Current research suggests that melatonin therapy may help treat uveitis, a common inflammatory eye disease. The related report by Sande et al., "Therapeutic Effect of Melatonin in Experimental Uveitis," appears in the December issue of The American Journal of Pathology. view more (2008-11-24)
Iressa proves just as effective as chemotherapy for lung cancer Gefitinib, also known as Iressa, the once-promising targeted therapy for the treatment of non-small cell lung cancer, has proven as effective as chemotherapy as a second-line therapy for the disease with far fewer side effects, according to an international Phase III clinical trial, led by... view more (2008-11-21)
Researcher tricks immune system in diabetic mice The body's immune system hates strangers. When its security patrol spots a foreign cell, it annihilates it. view more (2008-11-21)
In the war against diseases, nerve cells need their armor In a new study, researchers at the Montreal Neurological Institute (MNI), McGill University, and the Université de Montréal have discovered an essential mechanism for the maintenance of the normal structure of myelin, the protective covering that insulates and supports nerve cells... view more (2008-11-13)
Intraspinal implant of mesenchymal stem cells may not heal the demyelinated spinal cord Multiple sclerosis is a disease caused by the loss of the myelinated sheath surrounding the nerve fibers of the spinal cord. view more (2008-11-13)
The Next Step in Health Care: Telemedicine Imagine a scenario where doctors from different hospitals can collaborate on a surgery without having to actually be in the operating room. What if doctors in remote locations could receive immediate expert support from top specialists in hospitals around the world? view more (2008-11-13)
Stem Cells from Monkey Teeth Can Stimulate Growth and Generation of Brain Cells Researchers at the Yerkes National Primate Research Center, Emory University, have discovered dental pulp stem cells can stimulate growth and generation of several types of neural cells. Findings from this study, available in the October issue of the journal Stem Cells, suggest dental pulp stem... view more (2008-11-12)
First trial of gene therapy for advanced heart failure shows promising results Phase I results of the first clinical trial of gene therapy for patients with advanced heart failure show the approach to be promising, with improvements in several measures of the condition's severity. view more (2008-11-11)
Researchers use chemical from medicinal plants to fight HIV Like other kinds of cells, immune cells lose the ability to divide as they age because a part of their chromosomes known as a telomere becomes progressively shorter with cell division. As a result, the cell changes in many ways, and its disease fighting ability is compromised. view more (2008-11-10)
ESF workshop makes major advance in cancer radiotherapy Radical improvements in outcome for many cancer sufferers are in prospect following one of the most significant advances in radiotherapy since x-rays were first used to treat a tumour in 1904. view more (2008-11-07)
Multiple sclerosis research charges ahead with new mouse model of disease A new study highlights the role of a charge-switching enzyme in nervous system deficits characteristic of multiple sclerosis and other related neurological illness. view more (2008-11-06)
Tibotec presents interim findings for TMC435, an investigational genotype 1 hepatitis C treatment New clinical data show antiviral activity of TMC435, an investigational protease inhibitor (PI) being developed by Tibotec BVBA for the treatment of chronic hepatitis C virus (HCV) infection. view more (2008-11-04)
A License to Drive with ADHD If your teen can't pass a driver's test, it might not mean more time in driver's ed is needed. It might be due to ADHD. view more (2008-11-04)
Moores UCSD Cancer Center studying novel leukemia vaccine for high-risk patients Researchers at the Moores Cancer Center at the University of California, San Diego (UCSD) are conducting clinical trials of a novel therapy aimed at revving up the immune system to combat a particularly difficult-to-treat form of leukemia. view more (2008-11-04)
Lung airway cells activate vitamin D and increase immune response Vitamin D is essential to good health but needs to be activated to function properly in the human body. Until recently, this activation was thought to happen primarily in the kidneys, but a new University of Iowa study finds that the activation step can also occur in lung airway cells. view more (2008-11-04)
Type-1 diabetes not so much bad genes as good genes behaving badly, Stanford research shows Investigators combing the genome in the hope of finding genetic variants responsible for triggering early-onset diabetes may be looking in the wrong place, new research at the Stanford University School of Medicine suggests. view more (2008-10-31)
Oral rinses used for tracking HPV-positive head and neck cancers holds promise for cancer screening A study published in the journal Clinical Cancer Research, a journal of the American Association for Cancer Research, validates a non-invasive screening method with future potential for detection of human papillomavirus (HPV)-positive head and neck cancers. view more (2008-10-31)
Elderly fare better when included in decisions on treatment trade-offs Halting a medication that treats one ailment because it may worsen another is a treatment trade-off decision that elderly patients with multiple medical conditions would rather take part in, researchers at Yale School of Medicine report in a study published in the Journal of the American Geriatrics... view more (2008-10-29)
Scientist clears hurdles for muscular dystrophy therapy Approximately 250,000 people in the United States have some form of muscular dystrophy. Duchenne muscular dystrophy (DMD) is the most common type of the disease, predominantly affecting males. view more (2008-10-29)
Even mild sleep apnea increases cardiovascular risk People with even minimally symptomatic obstructive sleep apnea (OSA) may be at increased risk for cardiovascular disease because of impaired endothelial function and increased arterial stiffness, according to a study from the Oxford Centre for Respiratory Medicine in the UK. view more (2008-10-27)
Phase IIb data show that BG-12 significantly reduced brain lesions in multiple sclerosis Biogen Idec (NASDAQ: BIIB) today announced the publication of Phase IIb data showing that a 240 mg three-times-daily dose of the company's novel oral compound, BG-12 (BG00012, dimethyl fumarate), reduced the number of new gadolinium enhancing (Gd+) lesions by 69 percent in patients with... view more (2008-10-24)
| |
| Page
1 of
56 |
1391 Results |
|
|
|
Sort By:
Relevance | Page Views |
|
|